Alkem Laboratories Ltd has received approval for the allotment of equity shares from Sunsure Solarpark for its investment of 21.46% in renewable power, totaling Rs. 93,59,920; Enzene Biosciences has a 23.25% share with an investment of Rs. 1,01,39,808.